Copyright © 2001 by the European Society of Cardiology.
Editorials
Localized right ventricular morphological abnormalities in patients with the Brugada syndrome: what is their significance?
a Cardiovascular Research and Teaching Institute Aalst, Belgium
b Cardiovascular, Insitute, Hospital Clinic, University of Barcelona, Spain
c Baylor College of Medicine, Cardiology Department, Houston, Texas, U.S.A.
References
- Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol. 1992;20:13911396[Abstract]
- Corrado D, Nava A, Buja G. Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol. 1996;27:443448[Abstract]
- Fontaine G, Fontaliran F, Frank R. Arrhythmogenic right ventricular cardiomyopathies. Clinical forms and main differential diagnoses. Circulation. 1998;97:15321535
[Free Full Text] - Ohe, T, Idiopathic ventricular fibrillation of the Brugada type: An atypical form of arrhythmogenic right ventricular cardiomyopathy? Intern Med, 1996, 35, 595
- Chen Q, Kirsch GE, Zhang D. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998;392:293296[CrossRef][Medline]
- McKoy G, Protonotarios N, Crosby A. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet. 2000;355:21192124[CrossRef][Web of Science][Medline]
- Takagi M, Aihara N, Kuribayashi. Localized right ventricular morphological abnormalities detected by electron-beam computed tomography represent arrhythmogenic substrates in patients with the Brugada syndrome. Eur Heart J. 2001;22:10321041
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
S. Rolf, H.-J. Bruns, T. Wichter, P. Kirchhof, M. Ribbing, K. Wasmer, M. Paul, G. Breithardt, W. Haverkamp, and L. Eckardt The ajmaline challenge in Brugada syndrome: Diagnostic impact, safety, and recommended protocol Eur. Heart J., June 2, 2003; 24(12): 1104 - 1112. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
